Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bispecific antibody, reveals unique and consensus mechanisms of resistance

Kristina B. Emdal, Antje Dittmann, Raven J. Reddy, Rebecca S. Lescarbeau, Sheri L. Moores, Sylvie Laquerre, Forest M. White*

*Corresponding author for this work
10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bispecific antibody, reveals unique and consensus mechanisms of resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences